Kelly Jackson's blog articles
In Silico Testing for Toxicology Assessment
Blog articles
Toxicity assessment is a key part of the drug discovery and development process. Many of the tests that use laboratory animals to investigate drug safety are time-consuming, expensive and complicated by ethical concerns. Investigative toxicology strategies have therefore adopted a tiered approach employing in silico and in vitro methods in order to ideally eliminate, or at least reduce, in vivo experimentation. Here, we attempt to give a simplified overview of the complex and multifaceted topic that is in silico toxicology assessment. Strap in and hold on tight…
Medical devices and CE certification
Blog articles
A medical device placed on the EU market must have a CE (“Conformité Européenne”) certification and comply with the EU Medical Devices Regulation (MDR; Regulation (EU) 2017/745) [1] or the EU In Vitro Diagnostic Medical Devices Regulation (IVDR; Regulation (EU) 2017/746) [2]. Read our overview on the process, plus find out how we can help.
Safe Cosmetic Testing Methods without Animals
Blog articles
Shampoo, perfume, lipstick, toothpaste – we all use at least some cosmetics in our everyday lives, and assume the manufacturers and regulatory agencies have our best health interests at heart. Here, we provide an overview on the use of laboratory animals in cosmetic safety testing, and discuss alternative non-animal-based test methods.
The Importance of Safety Pharmacology Testing of Human Pharmaceuticals
Blog articles
Progression of a new pharmaceutical/drug from the laboratory to clinical trials requires it to have both a recognised health benefit and an acceptably-low risk of inducing adverse effects. By identifying undesirable effects and their underlying mechanisms, safety pharmacology studies are an essential component of the drug development process. Here, we’ll review the importance of safety pharmacology testing in human pharmaceuticals.